Kinetics of red blood cell T3 uptake in hypothyroidism with or without hormonal replacement, in the rat

Citation
X. Moreau et al., Kinetics of red blood cell T3 uptake in hypothyroidism with or without hormonal replacement, in the rat, J ENDOC INV, 22(4), 1999, pp. 257-261
Citations number
20
Categorie Soggetti
Endocrinology, Nutrition & Metabolism
Journal title
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
ISSN journal
03914097 → ACNP
Volume
22
Issue
4
Year of publication
1999
Pages
257 - 261
Database
ISI
SICI code
0391-4097(199904)22:4<257:KORBCT>2.0.ZU;2-5
Abstract
L-triiodothyronine (L-T3) is taken up and accumulated into red blood cells (RBC) by means of a specific carrier-mediated system. The aim of this study was to evaluate the reactivity of this system in relation to induced alter ations in thyroid hormone (TH) supply. We investigated the kinetic paramete rs (Vmax, maximal velocity and Km, Michaelis constant) of washed-RBC L-T3 u ptake 1) in thyroidectomized (TXT)) rats, 2) in TXT rats administered with low doses of L-T4 (15 mu g/kg/day x 14) to restore normal serum TH levels ( REPL), 3) in TXT rats administered with high doses of L-T4 (200 mu g/kg/day x14) to achieve a large increase in serum TH levels (HIGH). Serum free T3 a nd T4 levels were significantly decreased in TXT rats (2.4 and 8.8 fold, re spectively), not different in REPL rats and significantly increased in HIGH rats (2.4 and 3 fold, respectively) compared to sham-operated rats (SHAM). Both kinetics of RBC L-T3 uptake were significantly increased in TXT rats (Vmax+/-SE in pmol/min/10(8) cells=235.1+/-11.1, p<0.05 and Km+/-SE in nM=1 90.1+/-9.0, p<0.05), not different in REPL rats (Vmax=184.8+/-7.6 and Km=15 1.9+/-7.1) and significantly decreased in HIGH rats (Vmax=168.0+/-4.1, p<0. 01 and Km=131.9+/-4.6, p<0.01) compared to SHAM rats (Vmax=197.7+/-5.8 and Km=160.9+/-6.1). These results show that kinetics of RBC L-T3 uptake are mo dified in response to defect or excess in circulating TH levels. Since RBC play likely a role of a buffer system, the changes in carrier-mediated infl ux of L-T3 could be seen as a compensatory mechanism that counteract the di sturbances in the TH availability for the target tissues. (J. Endocrinol. I nvest. 22: 257-261, 1999) (C)1999, Editrice Kurtis.